# PGD2 Formation in Vascular Injury

> **NCT01001260** · — · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 51 (actual)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome
- Stable Angina

## Interventions

- **DRUG:** No ASA
- **DRUG:** Low dose ASA
- **DRUG:** 325 mg ASA

## Key facts

- **NCT ID:** NCT01001260
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2011-02
- **Final completion:** 2012-01
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Unable to find subjects that met inclusion/exclusion criteria.
- **Last updated:** 2019-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001260, "PGD2 Formation in Vascular Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01001260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
